Read more
The latest in the crucial series documenting scientific discoveries at the forefront of HIV and AIDS research!
This volume updates the most important and controversial issues facing physicians, nurses, microbiologists, pharmacists, and epidemiologists who deal directly with patients suffering from HIV and AIDS, focusing on specific areas in which important new advances have occurred in diagnosis, therapy, and prevention of infection and related complications.
Outlines new disease management strategies being tested in prospective clinical trials and observational studies!
Combining elements of virology, epidemiology, immunology, oncology, endocrinology, neurology, psychiatry, and the behavioral sciences, AIDS Clinical Review 2000/2001
clarifies substantive advancements in vaccine development, realistically assessing potential efficacy and limitations
explores short-term antiretroviral therapy for dramatically reducing the rate of vertical transmission from mother to child
evaluates the efficacy of antiretroviral prophylaxis for workers who experience high-risk exposure to HIV-infected blood
discusses preservation of HIV specific immunity when antiretroviral therapy is initiated early in the course of acute infection
considers complex drug interactions that occur when drugs are used in combination
highlights cytokine and other immune-based therapies
suggests chronic hepatitis may ultimately be more fatal than HIV for coinfected patients
and more!
Including results recently presented at scientific meetings but not yet published in peer-reviewed journals, AIDS Clinical Review 2000/2001 is essential reading for infectious disease specialists, epidemiologists, virologists, immunologists, pharmacologists, microbiologists, hematologists, hepatologists, oncologists, neurologists, medical students in these disciplines, and all medical professionals involved in both AIDS research and clinical practice.
List of contents
Human Immunodeficiency Virus Prevention: Applying the Lessons Learned
Thomas J. Coates, Anke A. Ehrhardt and David D. Celentano
Novel Strategies Toward the Development of an Effective Vaccine to Prevent Human Immunodeficiency Virus Infection or Acquired Immunodeficiency Virus
Barbara Ensoli and Aurelio Cafaro
Pediatric Human Immunodeficiency Virus Type 1 Infection: Updates on Prevention and Management
Ann J. Melvin and Lisa M. Frenkel
Risk of Human Immunodeficiency Virus Infection in Health Care Workers
Rita Fahrner
Can Immune Responses to Human Immunodeficiency Virus Be Preserved, Enhanced, or Restored?
Bruce D. Walker
Reconstitution of Immunity Against Opportunistic Infections in the Era of Potent Antiretroviral Therapy
Judith A. Aberg
Salvage Therapy for Patients Failing their Current Antiretroviral Regimen
Mary A. Albrecht
Drug Interactions of Antiretroviral Agents
Bradley W. Kosel and Francesca Aweeka
Rationale for Immune-Based Therapies for Human Immunodeficiency Virus Type 1 Infection
Michael M. Lederman and Hernan Valdez
Human Immunodeficiency Virus and Hepatitis B and C Coinfection: Pathogenic Interactions, Natural History, and Therapy
Arthur Y. Kim, Raymond T. Chung, and Bruce Polsky
About the author
Paul A. Volberding
Summary
Combining elements of virology, epidemiology, immunology, oncology, endocrinology, neurology, psychiatry, and the behavioral sciences. This book clarifies substantive advancements in vaccine development, realistically assessing potential efficacy and limitations. It is for infectious disease specialists, epidemiologists, virologists, and others.
